Pharmafile Logo
Pharmafocus logo
Advanced Search

Ebola

Showing 15 posts of 53 posts found.

GSK image

GSK launches Ebola Phase III trial in Liberia

January 23, 2015
Research and Development, Sales and Marketing Africa, Ebola, GSK, US National Institutes of Health, WHO, Wellcome Trust, liberia, newlink

A shipment of GSK’s potential vaccine against the Ebola virus disease is on its way to Liberia ready to be …

News
Rajeev Venkayya, president of Takeda Vaccines image

Interview: Rajeev Venkayya, president of Takeda Vaccine

January 19, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bush, Ebola, Gates, Rajeev Venkayya, Takeda, brett wells, vaccines

 Rajeev Venkayya is the president of the global vaccine business unit at Takeda Pharmaceuticals. He has served as special assistant …

Feature
Ebola image

UK nurse with Ebola in ‘critical condition’

January 6, 2015
Research and Development, Sales and Marketing Africa, Ebola, GSK, Mapp, WHO, cafferky, johnson, zmapp

A British nurse that was diagnosed with Ebola last week is said to be in a critical condition at the …

News

New hope through Ebola vaccine trial

December 23, 2014
Research and Development, Sales and Marketing Africa, Ebola, GAVI, GSK, US, marburg, uganda

A report in the Lancet medical journal has highlighted a treatment found to be well-tolerated in healthy Ugandan adults during …

News

Government plans £6 billion precision medicine strategy

December 18, 2014
Research and Development, Sales and Marketing ABPI, Cell Therapy Catapult, Ebola, George Osborne, UK, government

The government has committed to a £6 billion investment in scientific research and development as part of its science and …

News
GSK image

GSK Ebola vaccine gets EU support

December 17, 2014
Research and Development, Sales and Marketing EC, EU, Ebola, Europe, GSK, Merck, Takeda, Vaccine, WHO, johnson

A newly-formed European consortium is to help advance the development of GlaxoSmithKline’s promising Ebola vaccine. The consortium is backed by …

News
Merck image

Merck Ebola vaccine shows promise

December 4, 2014
Research and Development, Sales and Marketing Ebola, Merck, VSV-ZEBOV, WHO, hug, newlink genetics

Merck and NewLink Genetics’ experimental Ebola vaccine has shown no major side effects in its first trial according to the …

News
GSK image

GSK Ebola vaccine ‘promising’ in early trials

November 27, 2014
Research and Development, Sales and Marketing Africa, Ebola, GSK, Takeda, Vaccine, WHO, vaccines

The first trial results for GlaxoSmithKline’s (GSK) Ebola vaccine candidate have shown that the medicine was well-tolerated and produced an …

News
Ebola image

Takeda: we’re working on Ebola too

November 24, 2014
Research and Development, Sales and Marketing Ebola, GSK, Gates, Obama, WHO, brett wells, pharmafile, rajeev, vaccines, venkaya, venkayya

The president of Takeda Vaccines has told Pharmafile that the Japanese firm has identified compounds that could help prevent infection …

News
gary_nobel_sanofi

Sanofi appoints an Ebola response co-ordinator

November 19, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ebola, Sanofi, gary nobel

Former director of the NIH Vaccine Research Center Dr Gary Nabel has been hired by Sanofi to spearhead its contribution …

Appointment
MSF image

MSF starts trials of Ebola candidates

November 14, 2014
Research and Development, Sales and Marketing Ebola, MSF, Médecins Sans Frontières, avigan, brincidofovir, favipiravir

Three experimental Ebola therapies will be tested at sites operated by Médecins Sans Frontières (MSF) in West Africa, according to …

News
Ebola image

EU and drug industry set aside €280m for Ebola

November 7, 2014
Research and Development, Sales and Marketing Africa, Ebola, WHO, chan, vaccines, virus, west

The EU’s Innovative Medicines Initiative (IMI) has unveiled a new programme to find vaccines, drugs and diagnostics for Ebola, funded …

News
J&J image

J&J announces ‘major commitment’ to Ebola effort

October 22, 2014
Sales and Marketing Crucell, Ebola, J&J, JJ, Vaccine, bavarian, johnson, niaid

Johnson & Johnson will invest $200 million to accelerate and significantly expand the production of its Ebola vaccine programme. The …

News
Ebola image

GSK: Ebola vaccines will come ‘too late’

October 17, 2014
Manufacturing and Production, Research and Development, Sales and Marketing Ebola, GSK, JK-05, Sihuan, tekmira, vaccines, zmapp

GlaxoSmithKline says its potential Ebola vaccine will come ‘too late’ for the current outbreak despite being fast-tracked. In August the …

News
Colorised transmission electron micrograph of Ebola virus virion

Chinese military-linked firm says it has Ebola cure

October 14, 2014
Medical Communications, Sales and Marketing Ebola, WHO, amms, brincidofovir, sihuan pharmaceutical holdings, tekmira, zmapp

A Chinese drugmaker that has close military ties is seeking fast-track approval for its JK-05 drug that it says can …

News

Latest content

Regeneron shares data for multiple myeloma treatment

December 8, 2023

Merck collaborates with Acceleration Consortium for AI experimentation

December 8, 2023

AbbVie to acquire Cerevel Therapeutics for approximately $8.7bn

December 7, 2023

ONK Therapeutics and NAYA Biosciences enter partnership for NK cell therapy development

December 7, 2023

FDA approves Novartis’ Fabhalta for PNH treatment

December 6, 2023